Web platform for running 200+ molecular design AI models at scale
Tamarind Bio wraps leading open-source protein design and molecular modeling tools (AlphaFold, Chai-1, RFdiffusion, ProteinMPNN) behind APIs and web interfaces, letting biopharma teams run hundreds of thousands of parallel simulations without managing GPUs. The stack is GPU-heavy (CUDA, Kubernetes, AWS GPU scaling) with Python + React on top, and the pain-point pattern—batch HPC scaling, ML inference deployment, and GPU cost management—suggests their primary friction is not the science but the operational complexity of running these models reliably at biotech scale.
Tamarind Bio operates an AI platform that abstracts away infrastructure overhead for computational molecular design. The core offering is a web interface and API layer over 200+ publicly available molecular design tools, enabling biopharma teams to design novel protein binders, optimize binding affinities, and evaluate antibody developability. Customers include top 20 pharmaceutical companies. The platform is engineered on Python, React, and AWS with heavy GPU orchestration (Kubernetes, Slurm, CUDA), supporting batch inference workloads that can span hundreds of GPUs in parallel. The team is primarily engineering-focused, with embedded research and field support.
Tamarind Bio provides access to 200+ molecular design tools, including AlphaFold, Chai-1, RFdiffusion, and ProteinMPNN. Users can run structure prediction, protein design, docking, and antibody developability scoring across up to hundreds of thousands of parallel inputs.
Python, React, AWS, CUDA, Kubernetes, Slurm, PyTorch, TensorFlow, DynamoDB, Terraform, Next.js, and TypeScript. The platform emphasizes GPU orchestration and batch inference at scale.
Other companies in the same industry, closest in size